Top APAC (Ex-China) Investment Worthy Healthcare Companies Using Smartkarma’s Smart Score Screener
We have screened APAC (ex-China) healthcare companies with market cap≥$800M using Smartkarma’s Smart Score and picked up 2 investable ideas by...
635 Views
Seegene (096530 KQ/Buy)Second Consecutive Earnings Surprise
For 2Q26, Seegene posted revenue of W136bn (+19% YoY), beating the consensus and marking a new quarterly record. This also marked the ninth...
93 Views
Korea Value Up Index - Surprising Inclusions and Exclusions
There are many surprising inclusions and exclusions in the Korea Value Up Index. We provide 30 companies that are surprising inclusions and 10...
1.6k Views
Seegene (C KQ/Buy) Annual OP Margin to Return to Double Digits for the First Time in Four Years
For 1Q26, Seegene reported revenue of W129.1bn (+11% YoY), in line with the consensus, and operating profit of W23.6bn (+59% YoY; OP margin of...
114 Views
Seegene (096530 KQ/Buy)In-Vitro Diagnostic Revenue of W500bn Within Reach
In-vitro diagnostic revenue of W500bn within reach4Q25 review: Revenue meets consensus; OP misses For 4Q25, Seegene posted revenue of W130
144 Views